{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:05:19Z","timestamp":1789243519859,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.bmcl.2022.128809","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:48:20Z","timestamp":1653094100000},"page":"128809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Synthesis of a new series of quinoline\/pyridine indole-3-sulfonamide hybrids as selective carbonic anhydrase IX inhibitors"],"prefix":"10.1016","volume":"70","author":[{"given":"Priti","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerella","family":"Sridhar Goud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baijayantimala","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kumar Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Choli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhoopendra","family":"Singh Kushwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata","family":"Madhavi Yaddanapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0158-5683","authenticated-orcid":false,"given":"Mohammed","family":"Arifuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2022.128809_b0005","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00018.2021","article-title":"Carbonic Anhydrases in Metazoan Model Organisms: Molecules, Mechanisms, and Physiology","author":"Aspatwar","year":"2022","journal-title":"Physiol Rev."},{"key":"10.1016\/j.bmcl.2022.128809_b0010","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/13543776.2013.780598","article-title":"Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005\u20132013)","volume":"23","author":"Carta","year":"2013","journal-title":"Expert OpinTher Pat."},{"key":"10.1016\/j.bmcl.2022.128809_b0015","first-page":"705","volume":"23","author":"Masini","year":"2013","journal-title":"Antiglaucoma carbonic anhydrase inhibitors: a patent review.Expert OpinTher Pat."},{"key":"10.1016\/j.bmcl.2022.128809_h0020","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J Enzyme Inhib Med Chem."},{"key":"10.1016\/j.bmcl.2022.128809_h0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert Opin Drug Discov."},{"key":"10.1016\/j.bmcl.2022.128809_b0025","doi-asserted-by":"crossref","unstructured":"a) Singh P, Sigalapalli DK, Goud NS, et. al. Ureidosulfocoumarin Derivatives as Selective and Potent Carbonic Anhydrase IX and XII Inhibitors. ChemMedChem. 2021;23.b) Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov.2008;7:168-81; b) Monti SM,Supuran CT,De Simone G. Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013). Expert OpinTher Pat.2013;23:737-49; c) Supuran CT. Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Med Chem.2011;3:1165-80.","DOI":"10.4155\/fmc.11.69"},{"key":"10.1016\/j.bmcl.2022.128809_b0030","doi-asserted-by":"crossref","unstructured":"a)Chandra KM, Goud NS, Arifuddin M, et al. Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors. Bioorg. Med. Chem. Lett; b)Goud NS, Kumar P, Dawn Bharath R. Recent Developments of Target-Based Benzimidazole Derivatives as Potential Anticancer Agents. In: P. Nandeshwarappa B, S. O. S, eds. Heterocycles - Synthesis and Biological Activities. IntechOpen; 2020; c) Thacker PS, Goud NS, Argulwar OS, et al. Synthesis and biological evaluation of some coumarin hybrids as selective carbonic anhydrase IX and XII inhibitors. Bioorg Chem. 2020;104:104272.","DOI":"10.1016\/j.bioorg.2020.104272"},{"key":"10.1016\/j.bmcl.2022.128809_b0035","doi-asserted-by":"crossref","unstructured":"Mohammad A. Biological Potential and Chemical Properties of Pyridine and Piperidine Fused Pyridazine Compounds: Pyridopyridazine a Versatile Nucleus, Asian J. Pharm. 2016;1:29-35; b) Husain A, Madhesia D. Heterocyclic compounds as carbonic anhydrase inhibitor. J Enzyme Inhib Med Chem.2012;27:773-83.","DOI":"10.18311\/ajcps\/2016\/7693"},{"key":"10.1016\/j.bmcl.2022.128809_h0045","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0968-0896(99)00190-X","article-title":"Carbonic Anhydrase Inhibitors: Synthesis of Water-Soluble, Topically E\u20acective Intraocular Pressure Lowering Aromatic\/Heterocyclic Sulfonamides Containing 8-Quinoline-sulfonyl Moieties: Is the Tail More Important than the Ring?","volume":"7","author":"Borras","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128809_h0050","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ejmech.2004.03.002","article-title":"QSAR study on carbonic anhydrase inhibitors: aromatic\/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents","volume":"39","author":"Agrawal","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128809_b0045","doi-asserted-by":"crossref","unstructured":"a)Mostafa M,Ghorab M,Ragab FA,Heiba HI,Arafa RK, El-Hossary EM.In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety Eur. J. Med. Chem. 2010;45:3677-3684; b)Alqasoumi SI,Al-Taweel,AM, Alafeefy AM,Noaman E,Ghora MM. Novel quinolines and pyrimido[4,5-b]quinolines bearing biologically active sulfonamide moiety as a new class of antitumor agents. Eur. J. Med. Chem.2010;45:738-744; c)M. M. Ghorab MM, RagabFA, HamedMM. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety. Eur. J. Med. Chem.2009;44:4211-4217; d)Thacker PS, Shaikh P, Angeli A, Arifuddin M, Supuran CT.Synthesis and biological evaluation of novel 8- substituted quinoline-2-carboxamides as carbonic anhydrase inhibitors J. Enzyme Inhib. Med. Chem.2019;34:1172-1177.","DOI":"10.1016\/j.ejmech.2010.05.014"},{"key":"10.1016\/j.bmcl.2022.128809_b0050","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ejmech.2004.03.002","article-title":"QSAR study on carbonic anhydrase inhibitors: aromatic\/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents","volume":"39","author":"Agrawal","year":"2004","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bmcl.2022.128809_h0065","article-title":"Pyridine moiety: An insight into recent advances in treatment of cancer","author":"Sahu","year":"2021","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmcl.2022.128809_h0070","first-page":"4879","article-title":"Synthesis and in vitro inhibition effect of new pyrido[2,3-d]pyrimidine derivatives on erythrocyte carbonic anhydrase I and II","volume":"59","author":"Kuday","year":"2014","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.bmcl.2022.128809_h0075","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/slct.201702562","article-title":"Synthesis, Biological Activity and Structure-Activity Relationship of Novel Diphenylurea Derivatives Containing Tetrahydroquinoline as Carbonic Anhydrase I and II Inhibitors","volume":"3","author":"Atahan","year":"2018","journal-title":"ChemistrySelect."},{"key":"10.1016\/j.bmcl.2022.128809_b0060","doi-asserted-by":"crossref","unstructured":"a) Monti SM, Meccariello A, Ceruso M, Szafra\u0144ski K, S\u0142awi\u0144ski J, Supuran CT. Inhibition studies of Brucellasuis \u03b2-carbonic anhydrases with a series of 4-substituted pyridine-3-sulphonamides. J Enzyme Inhib Med Chem.2018;33:255-259; b) S\u0142awi\u0144ski J, Szafra\u0144ski K, Vullo D, Supuran CT. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Eur J Med Chem.2013;69:701-10.","DOI":"10.1016\/j.ejmech.2013.09.027"},{"key":"10.1016\/j.bmcl.2022.128809_b0065","series-title":"IsNSM, Hagras M","first-page":"7","author":"Mohamed","year":"2021"},{"key":"10.1016\/j.bmcl.2022.128809_b0070","doi-asserted-by":"crossref","unstructured":"Abas M,Rafique H,ShamasS, Roshan S, AshrafZ,Iqbal Z, Raza H, Hassan M, Afzal K,Rizvanov AA,AsadMHHB. Sulfonamide-Based Azaheterocyclic Schiff Base Derivatives as Potential Carbonic Anhydrase Inhibitors: Synthesis, Cytotoxicity, and Enzyme Inhibitory Kinetics. Biomed Res Int.2020;20:8104107.","DOI":"10.1155\/2020\/8104107"},{"key":"10.1016\/j.bmcl.2022.128809_b0075","first-page":"e2100333","article-title":"Design and development of novel series of indole-3-sulfonamide ureido derivatives as selective carbonic anhydrase II inhibitors","volume":"25","author":"Singh","year":"2021","journal-title":"Arch Pharm (Weinheim)."},{"key":"10.1016\/j.bmcl.2022.128809_b0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejmech.2019.01.066","article-title":"Identification of an indol-based multi-target kinase inhibitor through phenotype screening and target fishing using inverse virtual screening approach","volume":"167","author":"Ostacolo","year":"2019","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bmcl.2022.128809_b0085","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/14756366.2019.1629432","article-title":"Synthesis of a new series of 3-functionalised-1-phenyl-1,2,3-triazole sulfamoylbenzamides as carbonic anhydrase I, II, IV and IX inhibitors","volume":"34","author":"Swain","year":"2019","journal-title":"J Enzyme Inhib Med Chem."},{"key":"10.1016\/j.bmcl.2022.128809_b0090","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/cmdc.202000915","article-title":"Coumarin-Thiourea Hybrids Show Potent Carbonic Anhydrase IX and XIII Inhibitory Action","volume":"16","author":"Thacker","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2022.128809_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115090","article-title":"Synthesis and exploration of 2-morpholino-4-phenylthiazol-5-yl acrylamide derivatives for their effects against carbonic anhydrase I, II, IX and XII isoforms as a non-sulfonamide class of inhibitors","volume":"27","author":"Swain","year":"2019","journal-title":"Bioorg Med Chem."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22002852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22002852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:45:10Z","timestamp":1760773510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22002852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":23,"alternative-id":["S0960894X22002852"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128809","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of a new series of quinoline\/pyridine indole-3-sulfonamide hybrids as selective carbonic anhydrase IX inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128809"}}